PATENT CLAIM ANALYSIS

Application Number: 16022481
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
Means and methods for therapeutic intervention of mitochondrial disorders or diseases, and in particular to a method for the treatment, prevention and/or amelioration of a disorder or disease correlated with mitochondrial stress or dysfunction, a mitochondrial disorder or disease, or a disorder or disease characterized by OPA1 alterations are disclosed. Thereby, a pharmaceutically active amount of a compound capable of modulating the activity of OMA1 and/or an oligomeric complex comprising OMA1 is administered to a patient in need of medical intervention. Methods of screening for a compound capable of modulating the activity of OMA1 and/or an oligomeric complex comprising OMA1 are disclosed. Methods for determining the susceptibility for, predisposition for, or the presence of such a disorder or disease and whether a person in need will benefit from the therapeutic intervention, i.e. personalized medicine are also disclosed.

Claim (Index 9):
The method of  claim 1 , wherein said compound comprises a biphenylsulfonamide.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 94.0
- Lexical Diversity: 2.17391
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13402933', '12094787', '10290461', '15158689', '14530049']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7500875018399377
- 35 USC 102 Novelty (BERT): 0.5229697347379286
- Combined Prediction Score: 0.7273757251297368
- Mean Citation Score: 207.559738
- Max Citation Score: 268.74496
- Similarity Product: 145.22728509246824

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test